We are live on ! Find out more
Boston Trust Walden

Boston Trust Walden Portfolio holdings

AUM $13.1B Turnover 6.42%
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10
Avg Time Held
3.1 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
2.1 years

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH icon
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.91%
2 Healthcare 16.24%
3 Technology 15.4%
4 Industrials 13.98%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NTRS icon
26
Northern Trust
NTRS
$30.3B
$62.6M 0.92%
627,112
+23,210
+4% +$2.21M
2013 Q2
18 quarters
CB icon
27
Chubb
CB
$136B
$62.3M 0.91%
426,628
-4,593
-1% -$686K
2016 Q1
7 quarters
MTD icon
28
Mettler-Toledo International
MTD
$32.8B
$59.6M 0.87%
96,219
-11,136
-10% -$7.12M
2013 Q2
18 quarters
OMC icon
29
Omnicom Group
OMC
$22.1B
$57M 0.84%
782,595
-93,555
-11% -$6.71M
2013 Q2
18 quarters
DCI icon
30
Donaldson
DCI
$10.2B
$56.2M 0.82%
1,148,633
-13,831
-1% -$659K
2013 Q2
18 quarters
UPS icon
31
United Parcel Service
UPS
$83.2B
$55.8M 0.82%
468,674
-2,880
-0.6% -$338K
2013 Q2
18 quarters
PPG icon
32
PPG Industries
PPG
$24B
$55M 0.81%
470,950
+31,860
+7% +$3.67M
2013 Q2
18 quarters
XRAY icon
33
Dentsply Sirona
XRAY
$1.76B
$54.4M 0.8%
826,074
+10,363
+1% +$659K
2013 Q2
18 quarters
AXP icon
34
American Express
AXP
$212B
$53.5M 0.78%
538,660
+225
+0% +$21.4K
2013 Q2
18 quarters
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.13T
$52.8M 0.77%
266,227
+6,835
+3% +$1.3M
2013 Q2
18 quarters
WAT icon
36
Waters Corp
WAT
$43.6B
$51.1M 0.75%
264,407
-989
-0.4% -$191K
2013 Q2
18 quarters
SBUX icon
37
Starbucks
SBUX
$110B
$49.9M 0.73%
868,183
+21,620
+3% +$1.22M
2014 Q4
12 quarters
ES icon
38
Eversource Energy
ES
$24.9B
$49.2M 0.72%
778,104
+14,473
+2% +$915K
2013 Q2
18 quarters
STT icon
39
State Street
STT
$46B
$49M 0.72%
502,072
+6,435
+1% +$615K
2013 Q2
18 quarters
LECO icon
40
Lincoln Electric
LECO
$14.2B
$46.8M 0.69%
510,638
+115,841
+29% +$10.6M
2013 Q2
18 quarters
TROW icon
41
T. Rowe Price
TROW
$21.6B
$44.2M 0.65%
421,080
-8,890
-2% -$867K
2013 Q2
18 quarters
CL icon
42
Colgate-Palmolive
CL
$73.9B
$44.1M 0.65%
585,070
-13,690
-2% -$1,000K
2013 Q2
18 quarters
ED icon
43
Consolidated Edison
ED
$40.6B
$42.9M 0.63%
504,728
-5,370
-1% -$461K
2015 Q1
11 quarters
XOM icon
44
ExxonMobil
XOM
$718B
$42.6M 0.62%
509,508
-8,557
-2% -$708K
2013 Q2
18 quarters
OGS icon
45
ONE Gas
OGS
$4.69B
$42.1M 0.62%
575,244
-5,243
-0.9% -$397K
2014 Q3
13 quarters
EMR icon
46
Emerson Electric
EMR
$90.4B
$42.1M 0.62%
604,123
-16,654
-3% -$1.08M
2013 Q2
18 quarters
CINF icon
47
Cincinnati Financial
CINF
$25.7B
$42M 0.62%
560,467
-29,773
-5% -$2.22M
2013 Q2
18 quarters
COP icon
48
ConocoPhillips
COP
$170B
$39.6M 0.58%
722,209
+35,501
+5% +$1.83M
2013 Q2
18 quarters
MDT icon
49
Medtronic
MDT
$122B
$39.2M 0.57%
485,079
-28,467
-6% -$2.28M
2016 Q1
7 quarters
TFC icon
50
Truist Financial
TFC
$56.9B
$38.4M 0.56%
771,800
+158,940
+26% +$7.67M
2013 Q2
18 quarters

Similar funds

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.